Repurposing of FDA-approved drugs against cancer - focus on metastasis

Aging

Volumn 8, Issue 4, 2016, Pages 567-568

  Ozsvari, Béla ^a   Lamb, Rebecca ^a   Lisanti, Michael P ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

antibiotics; aspirin; repurposing; tumor metastasis

Indexed keywords

ANTINEOPLASTIC AGENT;

DRUG REPOSITIONING; HUMAN; NEOPLASM;

ANTINEOPLASTIC AGENTS; DRUG REPOSITIONING; HUMANS; NEOPLASMS;

EID: 85016444503     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/AGING.100941     Document Type: Article

References (6)

1. 1. Wan L, et al. Oncotarget. 2015; 6: 35157-35172. Doi: 10.18632/oncotarget.6038.
2. 2. Algra AM, et al. The Lancet Oncology. 13; 518 - 527.
3. 3. http://www.addaspirintrial.org/
4. 4. Lamb R, et al. Oncotarget. 2015; 6:14005-14025. Doi: 10.18632/oncotarget.4159
5. 5. Pulvino M, et al. Oncotarget. 2015; 6:14796-14813. Doi: 10.18632/oncotarget.4193
6. 6. Hu H, et al. Oncotarget. 2015; doi: 10.18632/oncotarget.6419. [Epub ahead of print].